Phase 2 Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- (Phase 1 only) You have been diagnosed with a solid tumor cancer that has spread and cannot be removed by surgery.
- (Phase 2 only) Your tumor has been tested and found to have a specific gene change called a RET rearrangement, fusion, or certain RET mutation.
- You are able to carry out basic daily activities, ranging from fully active to capable of self-care but unable to work (confirm with trial site).
- Your cancer can be measured or tracked using standard imaging scans.
- Your blood, liver, and kidney functions are at acceptable levels.
- You are expected to live for at least 12 weeks.
- If you are a woman who could become pregnant, you have a negative pregnancy test (urine or blood).
- You are willing to provide a tumor tissue sample, either from a previous biopsy or a new one.
Who may not be able to join:
- Your cancer is primarily driven by a gene change other than RET.
- You have received certain chemotherapy drugs (nitrosourea, anthracyclines, or mitomycin) within the last 6 weeks.
- You have had chemotherapy, immunotherapy, radiation therapy, or major surgery within the past 4 weeks (or longer, depending on the specific treatment).
- You have received a large amount of radiation to your bone marrow or widespread radiation therapy within the past 4 weeks (or 2 weeks for palliative/pain-relief radiation).
- You have taken traditional Chinese herbal medicine for cancer treatment within the past week.
- You have received a live vaccine within the past 4 weeks.
- You are currently in another clinical trial or have received an experimental treatment within the past 4 weeks (or longer, depending on the treatment).
- You still have significant side effects from a previous cancer treatment that have not resolved.
- You have cancer that has spread to the brain or spinal cord and is causing worsening neurological symptoms.
- You have been diagnosed with another type of cancer within the past 5 years.
- You have a history of serious heart disease.
- You have active hepatitis B, active hepatitis C, or HIV.
- You have active lung inflammation or lung disease that requires treatment.
- You have fluid build-up around your lungs, abdomen, or heart that is not well controlled.
- You have a condition that seriously affects your ability to swallow or absorb medication through your digestive system.
- You have taken certain strong medications that affect how the body processes drugs (strong CYP3A inhibitors or inducers) within the past 2 weeks, or proton pump inhibitors (such as omeprazole) within the past week (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Phase 1: MTD and RP2D of HEC169096; Phase 2: Overall Response Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.